Demonstration Formulary
6 Endocrine system
06-07-02 Gonadorelin analogues
| Goserelin |
|
Formulary
|
BRANDS
|
 CKS guideline: Management of confirmed endometriosis- Secondary Care treatments |
|
| Leuprorelin Prostap 3 DCS® |
|
Formulary
|
|
CKS guideline: Management of confirmed endometriosis - Secondary Care treatments |
|
|
| Leuprorelin Prostap SR DCS® |
|
Formulary
|
|
CKS guideline: Management of confirmed endometriosis - Secondary Care treatments |
|
|
| Triptorelin Decapeptyl SR® |
|
Formulary
|
|
CKS guideline: management of confirmed endometriosis - Secondary Care treatements |
|
|
| Triptorelin Salvacyl® |
|
Formulary
|
|
CKS guideline: management of confirmed endometriosis - Secondary Care treatements |
|
Links
- CKS guideline: management of confirmed endometriosis - Secondary Care treatements
- CKS guideline: management of confirmed endometriosis - Secondary Care treatements
- CKS guideline: Management of confirmed endometriosis - Secondary Care treatments
- CKS guideline: Management of confirmed endometriosis - Secondary Care treatments
- CKS guideline: Management of confirmed endometriosis- Secondary Care treatments
- DVLA guidance
- MHRA cabergoline
- NICE CG156: Fertility problems: assessment and treatment
- NICE CG156: Fertility problems: assessment and treatment
- NICE Guidance on prescribing
- NICE NG28: Type 2 diabetes in adults: management